Express Pharma
Home  »  Latest Updates  »  US antitrust enforcers give Roche approval to buy Spark Therapeutics

US antitrust enforcers give Roche approval to buy Spark Therapeutics

The FTC approved the deal, which was originally announced in February, without requiring any asset sales to ensure that the planned merger complies with antitrust law, the agency said in a statement

0 51
Read Article

Swiss drugmaker Roche has won US antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics, the Federal Trade Commission reported, clearing the way for the Swiss drugmaker’s push into treating rare diseases including hemophilia A.

The FTC approved the deal, which was originally announced in February, without requiring any asset sales to ensure that the planned merger complies with antitrust law, the agency said in a statement.

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Want to know more about "Omic's" and it's relevance?
Register Now
close-image